AstraZeneca touts China expansion, positive CHMP opinions
AstraZeneca touts China expansion, positive CHMP opinions Published: Jun 30, 2022 By Mark Terry BioSpace AstraZeneca had a very busy week of
AstraZeneca touts China expansion, positive CHMP opinions Published: Jun 30, 2022 By Mark Terry BioSpace AstraZeneca had a very busy week of
AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial 3:28 AM EDT June 30 (Reuters) – AstraZeneca (AZN.L) said on Thursday
AstraZeneca, Ionis eye U.S. approval after positive trial data June 21, 2022, 5:54 AM EDT By Natalie Grover LONDON, June 21 (Reuters) – An
AstraZeneca rumored to have set sights on Mereo BioPharma buyout Published: Jun 17, 2022 By Tristan Manalac BioSpace Pharmaceutical
Pharma annual report: Brand values surge The values of leading pharmaceutical brands have skyrocketed during the COVID-19 pandemic; Johnson &
The race is on as Sanofi-GSK booster bests Pfizer-BioNTech Published: Jun 13, 2022 By Mark Terry BioSpace Although a handful of companies have
GSK closer to cracking elusive vaccine for common respiratory virus June 10, 2022, 4:40 AM EDT By Natalie Grover LONDON, June 10 (Reuters) – GSK
AstraZeneca’s Evusheld successfully prevents progression to severe COVID-19 Published: Jun 08, 2022 By Hannah Chudleigh BioSpace AstraZeneca
New data sets stage for broader use of AstraZeneca breast cancer drug June 5, 2022, 8:18 AM EDT By Natalie Grover LONDON, June 5 (Reuters) –
The following article, AstraZeneca COVID-19 Vaccine Shown to Cause Serious Neurological Disorder, was first published on Big League
In Part 1, I presented evidence showing the global COVID-19 'pandemic' was not a surprise viral outbreak but a pre-planned false flag event years in
Cancer treatments may benefit from lessons of pandemic setbacks – AstraZeneca executive May 26, 2022, 7:13 PM EDT By Divya Chowdhury and Lisa
Study: mRNA vaccines perform better against COVID-19 variants of concern Published: May 18, 2022 By Vanessa Doctor, RN BioSpace In a peer-reviewed
AstraZeneca boosts COVID portfolio with RQ Bio deal May 17, 2022, 4:34 AM EDT By Natalie Grover LONDON, May 17 (Reuters) – AstraZeneca (AZN.L)
Positive Clinical Results Advance Treatments For Multiple Myeloma, Asthma, Alzheimer’s Published: May 16, 2022 By Hannah Chudleigh BioSpace In